G
GemPharmatech Co Ltd
SSE:688046
GemPharmatech Co Ltd
SSE:688046
Price:
18.75
CNY
10.55%
Market Cap:
¥3.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
G
|
GemPharmatech Co Ltd
SSE:688046
|
CN |
|
H
|
Hipay Group SA
LSE:0RA7
|
FR |
|
H
|
HD Renewable Energy Co Ltd
TWSE:6873
|
TW |
|
S
|
Song Hong Garment JSC
VN:MSH
|
VN |
|
Shanta Gold Ltd
LSE:SHG
|
GG |
|
Lider Faktoring AS
IST:LIDFA.E
|
TR |
|
ADVA Optical Networking SE
XETRA:ADV
|
DE |
|
B
|
Bluerock Homes Trust Inc
AMEX:BHM
|
US |
|
G
|
Gifu Landscape Architect Co Ltd
TSE:1438
|
JP |
|
Kiplin Metals Inc
F:17G1
|
CA |
|
UTZ Brands Inc
NYSE:UTZ
|
US |
|
Far Eastern New Century Corp
TWSE:1402
|
TW |
|
BIOLASE Inc
OTC:BIOLQ
|
US |
|
A
|
Avi-Tech Holdings Ltd
SGX:1R6
|
SG |
|
M
|
Moorim P&P Co Ltd
KRX:009580
|
KR |
Cash Flow Statement
Cash Flow Statement
GemPharmatech Co Ltd
GemPharmatech Co Ltd
Currency: CNY
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||
| Stock-Based Compensation |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
(27)
|
(31)
|
(9)
|
(6)
|
(3)
|
11
|
(7)
|
(4)
|
(3)
|
(16)
|
(29)
|
(36)
|
(41)
|
(37)
|
(28)
|
(25)
|
|
| Change in Working Capital |
(170)
|
(193)
|
(192)
|
(226)
|
(242)
|
(266)
|
(275)
|
(306)
|
(317)
|
(331)
|
(351)
|
(361)
|
(386)
|
(390)
|
(400)
|
(395)
|
|
| Cash from Operating Activities |
113
N/A
|
96
-15%
|
125
+30%
|
122
-2%
|
106
-13%
|
118
+11%
|
110
-7%
|
96
-13%
|
117
+21%
|
78
-33%
|
47
-40%
|
64
+36%
|
90
+42%
|
116
+29%
|
149
+28%
|
193
+30%
|
|
| Investing Cash Flow | |||||||||||||||||
| Capital Expenditures |
(89)
|
(110)
|
(141)
|
(148)
|
(190)
|
(189)
|
(217)
|
(212)
|
(206)
|
(214)
|
(189)
|
(164)
|
(114)
|
(109)
|
(112)
|
(119)
|
|
| Other Items |
(265)
|
151
|
(761)
|
(806)
|
(804)
|
(723)
|
238
|
365
|
187
|
245
|
313
|
41
|
273
|
(180)
|
(326)
|
(369)
|
|
| Cash from Investing Activities |
(354)
N/A
|
41
N/A
|
(902)
N/A
|
(954)
-6%
|
(995)
-4%
|
(912)
+8%
|
22
N/A
|
153
+612%
|
(19)
N/A
|
31
N/A
|
124
+299%
|
(123)
N/A
|
159
N/A
|
(288)
N/A
|
(437)
-52%
|
(487)
-11%
|
|
| Financing Cash Flow | |||||||||||||||||
| Net Issuance of Debt |
14
|
(10)
|
(13)
|
(30)
|
(13)
|
28
|
46
|
77
|
64
|
53
|
61
|
(9)
|
12
|
55
|
132
|
187
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(1)
|
(17)
|
(18)
|
(18)
|
(19)
|
(68)
|
(80)
|
(80)
|
(81)
|
(61)
|
|
| Other |
(4)
|
(4)
|
1 027
|
1 028
|
1 027
|
1 027
|
(4)
|
(5)
|
(7)
|
(31)
|
(32)
|
(33)
|
(41)
|
(20)
|
(14)
|
(21)
|
|
| Cash from Financing Activities |
10
N/A
|
(14)
N/A
|
1 014
N/A
|
998
-2%
|
1 014
+2%
|
1 055
+4%
|
41
-96%
|
55
+33%
|
39
-28%
|
4
-90%
|
11
+169%
|
(110)
N/A
|
(109)
+1%
|
(46)
+58%
|
37
N/A
|
105
+182%
|
|
| Change in Cash | |||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(1)
|
1
|
2
|
3
|
2
|
4
|
2
|
1
|
1
|
(1)
|
(2)
|
1
|
2
|
2
|
2
|
|
| Net Change in Cash |
(231)
N/A
|
123
N/A
|
237
+93%
|
169
-29%
|
128
-24%
|
263
+105%
|
177
-33%
|
306
+73%
|
138
-55%
|
115
-17%
|
181
+58%
|
(171)
N/A
|
141
N/A
|
(217)
N/A
|
(248)
-15%
|
(186)
+25%
|
|
| Free Cash Flow | |||||||||||||||||
| Free Cash Flow |
24
N/A
|
(14)
N/A
|
(16)
-17%
|
(25)
-58%
|
(84)
-231%
|
(71)
+16%
|
(107)
-50%
|
(116)
-8%
|
(89)
+23%
|
(136)
-52%
|
(142)
-5%
|
(101)
+29%
|
(23)
+77%
|
7
N/A
|
37
+400%
|
75
+100%
|
|
Switch to:
Switch to:
See Also
Discover More
